Halozyme Therapeutics ROA - Return on Assets 2010-2024 | HALO

Halozyme Therapeutics return on assets for the quarter ending September 30, 2024 was 20.46.

  • Halozyme Therapeutics average return on assets for 2023 was 13.28, a 43.18% increase from 2022.
  • Halozyme Therapeutics average return on assets for 2022 was 23.37, a 31.12% decline from 2021.
  • Halozyme Therapeutics average return on assets for 2021 was 33.93, a 4194.94% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Halozyme Therapeutics ROA - Return on Assets 2010-2024 | HALO

  • Halozyme Therapeutics average return on assets for 2023 was 13.28, a 43.18% increase from 2022.
  • Halozyme Therapeutics average return on assets for 2022 was 23.37, a 31.12% decline from 2021.
  • Halozyme Therapeutics average return on assets for 2021 was 33.93, a 4194.94% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.